Executive Vice President of $ALGN sells 7,969 shares in insider sale

John Morici, the Executive Vice President (EVP) of $ALGN, recently divested a portion of his holdings in the company. On February 18, 2026, Morici sold a total of 7,969 shares, amounting to an estimated value of $1,508,645. This transaction represented approximately 49.2% of his current stake in this class of $ALGN stock, leaving him with 8,237 shares.

Insider trading activity for $ALGN has been relatively quiet, with only one transaction occurring in the past six months. Apart from Morici’s sale, there have been no other purchases, indicating a lack of significant movement in insider sentiment towards the company.

In contrast, hedge fund activity for $ALGN has been more pronounced, with notable changes in institutional investor positions. Over the recent quarter, 328 institutional investors have increased their stake in $ALGN, while 460 have reduced their holdings. Notable moves include UBS AM, a distinct business unit of UBS Asset Management Americas LLC, liquidating 2,104,365 shares, representing an 81.9% decrease in their portfolio value.

On the revenue front, $ALGN reported revenues of $1 billion in the fourth quarter of 2025, reflecting a 5.26% growth compared to the previous year. This positive revenue trend indicates a potential upswing in the company’s financial performance, which could bode well for future investor sentiment.

Congressional stock trading activity related to $ALGN has been limited, with one sale recorded in the past six months. Representative Lisa C. McClain divested up to $15,000 worth of $ALGN stock on September 11, 2025, reflecting minimal activity from members of Congress in trading the company’s shares.

In terms of analyst ratings, $ALGN has received mostly positive outlooks from Wall Street analysts. Four firms have issued buy ratings for the stock, with no sell ratings reported. The recent analyst ratings point to a favorable outlook on the company’s performance, potentially driving investor confidence in $ALGN’s future prospects.

Several analysts have offered price targets for $ALGN, with a median target of $200.0. Noteworthy targets include Sidharth Sahoo from HSBC setting a target price of $200.0 and Jason Bednar from Piper Sandler setting a target price of $220.0. These price targets provide investors with an indication of where analysts believe the stock price could trend in the future.

In conclusion, the recent insider sale by John Morici, coupled with hedge fund activity, revenue growth, and analyst outlook, provides a comprehensive overview of $ALGN’s current standing in the market. Investors may consider these factors when making informed decisions about their investment positions in the company.